Ashvin Limbachiya, Ahmedabad.
29 August 2023:
Torque Pharmaceuticals – a leading name in the pharmaceutical industry, has named DENTSU CREATIVE PR as its public relations agency. The account was won following a multi-agency pitch and will be serviced from the agency’s Gurugram office.
As per the mandate, DENTSU CREATIVE PR will leverage its extensive expertise to steer the brand’s communication strategy and oversee media relations. With a wealth of experience in the healthcare and pharmaceutical domains, the agency is poised to harness its proficiency to enhance the brand’s visibility & market presence and cultivate a meaningful connection with the target audience.
Aligned with Torque Pharmaceuticals’ exceptional journey as one of the fastest-growing entities in the pharmaceutical realm, this collaboration is positioned to further fortify the brand’s standing within the industry.
It is pertinent to note here that Torque Pharmaceuticals is recognized for delivering healthcare solutions of unparalleled quality. The brand’s ongoing commitment to pioneering innovation in the field of affordable medicines is a demonstration of its firm pursuit of excellence.
A.I.S Bedi, Managing Director, Torque Pharmaceuticals said, “We are elated to welcome DENTSU CREATIVE PR to our fold. Their strategic acumen and expertise in the pharmaceutical, health and FMCG space promise to substantially enhance our market positioning.”
Mandeep Singh, Executive Director, Torque Pharmaceuticals added, “We are looking forward to working on innovative and ingenious concepts that will amplify our engagement with stakeholders, effectively conveying our mission to improve the quality of life, in conjunction with our PR agency.”
Sanjeev Anand, President, DENTSU CREATIVE PR commented, “At DENTSU CREATIVE, we are driven by our strong commitment to infuse supreme creativity and innovation into every aspect of our partnerships. This synergy fuels our ambition to formulate strategies that not only achieve immediate objectives but also cultivate lasting connections. As we embark on this exciting chapter alongside Torque Pharmaceuticals, we are poised to set a new standard of collaboration that stands as a testament to creativity, innovation, and the pursuit of shared success.”
| The contents of this email and any attachments are confidential to Dentsu International Limited, its affiliated companies and the intended recipient(s) and may also be attorney-client privileged or otherwise protected by work product immunity or other legal rules. Any review, retransmission, dissemination or other use of or taking action in reliance upon this information by persons or entities other than the intended recipient(s) is prohibited. If you have received this email in error please contact the sender and delete the material from any computer. |
